Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.29

+0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (23684)	7/29/1998 1:50:00 PM
From: Henry Niman	Read Replies (1) of 32384

Speaking of fundamentals, I just read a post on a diabetes discussion group that indicated that clinical trials of 2nd and 3rd generation Rezulin compounds had been suspended. Is WLA developing 2nd and 3rd generation compounds of Rezulin, or are these trials of Sankyo? I'm trying to get a clarification if these suspended trials are actually Rezulin derivatives or competing compounds (like SBH's Avandia). Anyone have any info? Problems with TZDs should speed up rexinoid development by LLY or WLA, which of course would be a plus for LGND. Still haven't found any news, although WLA is down again today.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next